Pulmonary & Critical Care Fellowship Program
MGH-BIDMC Harvard

Eric Schmidt, MD

Eric Schmidt, MD

Division Chief, Pulmonary at MGH

Associate Professor of Medicine

Academic Interests

Our laboratory pursues "bedside-to-bench" investigations of the mechanisms underlying multisystem organ failure during sepsis, with specific attention to the roles of the endothelial and epithelial glycocalyces.

Awards and Recognition

  • Andrew M. Tager, MD Endowed Chair of Pulmonary and Critical Care Medicine (2024)

  • American Society for Clinical Investigation (2023)

  • Fellow of the American Thoracic Society, American Thoracic Society (2019)

  • Associate Editor, AJP-Lung, American Physiological Society (2019)

  • Permanent Member, Surgery Anesthesiology and Trauma Study Section (2019)

  • American Thoracic Society Pulmonary Circulation Assembly Early Career Research Achievement Award, American Thoracic Society (2015)

  • Giles F. Filley Memorial Award for Excellence in Respiratory Physiology and Medicine, American Physiological Society (2013)

  • Outstanding Early Career Scholar Award, University of Colorado Department of Medicine (2013)

More information can be found on Dr. Schmidt’s Harvard Catalyst Profile.

+Current Projects

Our laboratory uses human studies, focused preclinical models, and a large network of translational collaborators to pursue the following:

  • Investigating the mechanisms by which patient factors (i.e., age, sex, gender) and provider treatment decisions (i.e., fluid resuscitation strategies) shape endothelial glycocalyx injury during sepsis.
  • Understanding the mechanisms by which sex and gender influence epithelial glycocalyx degradation during lung injury in humans, and the impact of this degradation on alveolar surfactant dysfunction.
  • Understanding the glycobiological underpinnings of secondary bacterial pneumonia after viral infection.
  • Determining how the ultrastructure of the endothelial glycocalyx regulates homeostatic coagulation.